Evidence map›Paper›PMID 38756996›Full record

ReviewFrontiers in endocrinology2024

Discovery of metastases in thyroid cancer and "benign metastasizing goiter": a historical note.

Sergiy Kushchayev, Yevgeniya Kushchayeva, Tetiana Glushko, Iryna Pestun, Oleg Teytelboym

Erratum issuedAbstract readHistorical ArticleReview
In one paragraph

Review in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Redo Thyroidectomy: Updated Insights.Journal of clinical medicine · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Sergiy Kushchayev *Diabetes and Endocrinology Center, University of South Florida, Tampa, FL, United States.
Yevgeniya Kushchayeva *Department of Radiology, Moffitt Cancer Center, Tampa, FL, United States.
Tetiana GlushkoDepartment of Radiology, Moffitt Cancer Center, Tampa, FL, United States.
Iryna PestunDiabetes and Endocrinology Center, University of South Florida, Tampa, FL, United States.
Oleg TeytelboymDepartment of Radiology, Mercy Catholic Medical Center, Philadelphia, PA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the beginning of the eighteenth century, most physicians recognized cancer as an aggressive process that gradually spreads, leading to cachexia and death. Thyroid malignancies had long been underestimated because the majority of the population of West Europe suffered from diffuse goiters that masked malignant processes in the neck. Moreover, the life expectancy at that time was very low (about 37-40 years), so the majority of people died of other causes before metastatic thyroid cancer could develop and manifest. Nevertheless, in 1817, French dermatologist Jean Louis Alibert described the first case of a malignant tumor involving the thyroid gland. From the 1820s the number of case reports describing thyroid cancer increased. Even though Jean Claude Recamier described

Indexed as

GoiterThyroid NeoplasmsHistory, 18th CenturyHistory, 19th CenturyHistory, 20th CenturyHumansNeoplasm Metastasiscancergoiterhistorymalignanciesmetastasesthyroid

Identifiers

PMID38756996
PMCPMC11096462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.